Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

OVULATION INHIBITORS.

K M CROCKER, W D STITT

    Canadian Medical Association Journal
    |March 21, 1964
    PubMed
    Summary
    This summary is machine-generated.

    This study found that a low dose of norethindrone (2 mg) with mestranol (0.1 mg) was a highly effective contraceptive with minimal side effects. It also successfully treated menstrual disorders like dysmenorrhea and menorrhagia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diel interactions of oxygenic photosynthesis and n(2) fixation (acetylene reduction) in a marine microbial mat community.

    Applied and environmental microbiology·1987
    Same author

    Cloacal dysgenesis.

    Obstetrics and gynecology·1977
    Same author

    Recognition of sexual dysfunction in medical practice.

    Canadian Medical Association journal·1975
    Same author

    The copper IUD.

    Canadian Medical Association journal·1975
    Same author

    MENOMETRORRHAGIA: A NEW APPROACH TO THERAPY.

    Applied therapeutics·1964
    Same author

    The incompetent internal os of the cervix.

    American journal of obstetrics and gynecology·1963
    Same journal

    Tularaemia; a problem in diagnosis.

    Canadian Medical Association journal·2010
    Same journal

    CONTROL of cancer.

    Canadian Medical Association journal·2010
    Same journal

    Bilateral diphtheritic external otitis treated with sulfathiazole.

    Canadian Medical Association journal·2010
    Same journal

    Hypoplastic anaemia treated with transfusions and folic acid fraction.

    Canadian Medical Association journal·2010
    Same journal

    Lauron in rheumatoid arthritis; a further report.

    Canadian Medical Association journal·2010
    Same journal

    HOW the socialist looks at national health service in England.

    Canadian Medical Association journal·2010
    See all related articles

    Area of Science:

    • Reproductive Medicine
    • Pharmacology
    • Women's Health

    Background:

    • Oral contraceptives are widely used for family planning.
    • Assessing the efficacy and side effects of low-dose hormonal contraceptives is crucial.
    • Therapeutic benefits beyond contraception warrant investigation.

    Purpose of the Study:

    • To evaluate the contraceptive efficacy of 2 mg norethindrone with 0.1 mg mestranol.
    • To assess the side effects associated with this low-dose combination.
    • To explore other therapeutic benefits, particularly in managing menstrual irregularities.

    Main Methods:

    • A prospective study followed 185 women.
    • Data collected over 964 menstrual cycles (up to 15 months).
    • Focus on contraceptive use, pregnancies, side effects, and menstrual cycle characteristics.
    Keywords:
    CONTRACEPTIVES, ORALMENSTRUATION DISORDERSMESTRANOLNORETHINDRONETOXICOLOGIC REPORT

    Related Experiment Videos

    Main Results:

    • No pregnancies were reported among women using the method for contraception.
    • Reported side effects were minimal.
    • The low-dose regimen demonstrated effectiveness in managing dysmenorrhea, menorrhagia, and irregular menses.

    Conclusions:

    • The combination of 2 mg norethindrone and 0.1 mg mestranol is a safe and highly effective contraceptive option.
    • This formulation offers significant therapeutic advantages for women experiencing menstrual disorders.
    • Low-dose hormonal therapy presents a viable treatment for gynecological complaints.